These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34386463)

  • 21. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
    Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
    Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline.
    Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M
    J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA
    J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii.
    Chen L; Li X; Li D; Dong X; Chen H
    Ann Palliat Med; 2022 Feb; 11(2):490-497. PubMed ID: 35249326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence.
    Falagas ME; Kyriakidou M; Voulgaris GL; Vokos F; Politi S; Kechagias KS
    J Glob Antimicrob Resist; 2021 Mar; 24():342-359. PubMed ID: 33486122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal injection of tigecycline in treatment of multidrug-resistant
    Wang L; Zhang J; Yu X; Wang J; Cheng L; Hu S; Han G
    Eur J Hosp Pharm; 2017 May; 24(3):182-184. PubMed ID: 31156934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
    Rizek C; Ferraz JR; van der Heijden IM; Giudice M; Mostachio AK; Paez J; Carrilho C; Levin AS; Costa SF
    J Infect Chemother; 2015 Feb; 21(2):114-7. PubMed ID: 25456893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
    Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
    Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal and intraventricular antibiotics for postoperative Gram-negative meningitis and ventriculitis.
    Khan SA; Waqas M; Siddiqui UT; Shamim MS; Nathani KR; Jooma R; Mehmood F
    Surg Neurol Int; 2017; 8():226. PubMed ID: 29026662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of pan-drug resistant
    Theofanopoulos A; Fermeli D; Vekios D; Bizos A; Marangos M; Constantoyannis C; Panagiotopoulos V; Assimakopoulos SF
    Infez Med; 2022; 31(1):103-107. PubMed ID: 36908383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant
    Carrasco LDM; Dabul ANG; Boralli CMDS; Righetto GM; Carvalho ISE; Dornelas JV; Martins da Mata CPS; de Araújo CA; Leite EMM; Lincopan N; Camargo ILBDC
    Front Microbiol; 2021; 12():622704. PubMed ID: 33897637
    [No Abstract]   [Full Text] [Related]  

  • 38. Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations.
    Teo J; Lim TP; Hsu LY; Tan TY; Sasikala S; Hon PY; Kwa AL; Apisarnthanarak A
    Antimicrob Resist Infect Control; 2015; 4(1):2. PubMed ID: 25648393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against
    Zhu S; Yue J; Wang X; Zhang J; Yu M; Zhan Y; Zhu Y; Sy SKB; Lv Z
    Front Microbiol; 2023; 14():1217270. PubMed ID: 37455727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.